Combinatorial chemistry technology: method – library – apparatus – Library – per se – Library containing only organic compounds
Reexamination Certificate
2003-07-02
2010-02-02
Low, Christopher (Department: 1639)
Combinatorial chemistry technology: method, library, apparatus
Library, per se
Library containing only organic compounds
C506S030000, 53
Reexamination Certificate
active
07655602
ABSTRACT:
Disclosed are D-peptides and libraries of D-peptides comprising aromatic D-amino acids. Also disclosed are methods for identifying small D-peptides comprising aromatic D-amino acids that bind to proteins of interest.
REFERENCES:
patent: 5235028 (1993-08-01), Barany et al.
patent: 5753628 (1998-05-01), Heavner et al.
patent: 0018072 (1980-10-01), None
patent: 07-188282 (1995-05-01), None
patent: 09173062 (1995-12-01), None
patent: WO 92/04371 (1992-03-01), None
patent: WO 94/26296 (1994-11-01), None
patent: WO 97/13522 (1997-04-01), None
patent: WO 97/34923 (1997-09-01), None
patent: WO 00/62791 (2000-10-01), None
patent: WO 01/39796 (2001-06-01), None
Dooley et al. An all D-amino acid opioid peptide with central analgesic activity from a combinatorial library. 1994 Science 266:2019-2022.
Lam et al. A new type of synthetic peptide library for identifying ligand-binding activity 1991 Nature 354:82-84.
Satoh et al. Immobilization of saccharides and peptide on 96-will microtiter plates coated with methyl vinyl ether-maleic anhydride copolymer. 1998 Analytical Biochemistry 260:96-102.
Janda, 1994 PNAS 91:10779-10785.
R.B. Merrifield (1963 JACS 85:2149-2154).
Dougherty et al (1996 Science 271:163-168).
Komeda et al (1999 J. Molecular Catalysis B: Enzymatic 6:379-386).
Sugihara et al (2002 J. Biochem. 131:247-254).
Allured, V.S. et al., “Structure of exotoxin A ofPseudomonas aeruginosaat 3.0-Angstrom resolution,” Proc. Natl. Acad. Sci (1986) 83:1320-1324.
Appella, D.H. et al., “Residue-based control of helix shape in beta-peptide oligomers,” Nature (1997) 387(6631):381-384.
Choe, S. et al., “The crystal structure of diphtheria toxin,” Nature (1992) 357:216-222.
Cook, C.L. et al., “Simple purification methods for an alpha-Galactose-specific antibody from chicken eggs,” J. Biosci. & Bioeng. (2001) 91(3):305-310.
Craig, C. and Stitzel, R. eds., Modern Pharmacology, Little, Brown & Co., Boston (1986) 127-133.
Elliott, J.L. et al., “A quantitative study of the interactions ofBacillus anthracisedema factor and lethal factor with activated protective antigen,” Biochemistry (2000) 39:6706-6713.
Endo, Y. et al., “The RNA N-glycosidase activity of ricin A-chain,” J. Biol. Chem. (1988) 263:8735-8739.
Fryer, J.P. et al., “IgY antiporcine endothelial cell antibodies effectively block human antiporcine xenoantibody binding,” Xenotransplantation (1999) 56:98-109.
Galili, U., “The alpha-gal epitope (Galalpha1-3Galbeta 1-4GlcNAc-R) in xenotransplantation,” Biochimie (2001) 83:557-563.
Halloran, M.M. et al., “Ley/H: an endothelial-selective, cytokine-inducible, angiogenic mediator,” J. Immunol. (2000) 164:4868-4877.
Kadlec, R.P. et al., “Biological Weapons Control. Prospects and Implications for the Future,” J. Am. Med. Assoc. (1997) 278(5):351-356.
Kruszynski, M. et al., “Identification of TNF-alpha binding peptides from a D-amino acid hexapeptide library that specifically inhibit TNF-alpha binding to recombinant p55 receptor,” Cytokine (1999) 11(1):37-44.
Laduca, J.R. et al., “Targeting tumor necrosis factor alpha. New drugs used to modulate inflammatory diseases,” Dermatologic Clinics (2001) 19:617-635.
Lebl, M. et al., “One-bead-one-structure combinatorial libraries,” Biopolymers (Peptide Science) (1995) 37:177-198.
Letterio, J.J., “Murine models define the role of TGF-beta as a master regulator of immune cell function,” Cytokine & Growth Factor Reviews (2000) 11:81-87.
Lord, J.M. et al., “Ribosome inactivating proteins of plants,” Semin. Cell Biol. (1991) 2:15-22.
Massague, J., “How cells read TGF-beta signals,” Nature Review Mol. Cell Biol. (2000) 1:169-178.
Milne, J.C. et al., “Anthrax protective antigen forms oligomers during intoxication of mammalian cells,” J. Biol. Chem. (1994) 269(32):20607-20612.
Moberg,L.J. et al., “Affinity chromatography purification of type A botulinum neurotoxin from crystalline toxic complex,” Appl. Environ. Microbiol. (1987) 35(5):878-880.
Murphy, L.A. et al., “Five alpha-D-galactopyranosyl-binding isolectins fromBandeiraea simplicifoliaseeds,” J. Biol. Chem. (1977) 252:4739-4742.
Pinilla, C. et al., “All-D peptides recognized by an anti-carbohydrate antibody identified from a positional scanning library,” J. Mol. Biol. (1998) 283:1013-1025.
Remington's Pharmaceutical Sciences, 18th Edition, Mack Pub. Co., Easton, PA (1990).
Shapiro, R.E. et al., “Identification of a ganglioside recognition domain of tetanus toxin using a novel ganglioside photoaffinity ligand,” J. Biol. Chem. (1997) 272(48):30380-30386.
Speight, T, ed., Avery's Drug Treatment: Principles and Practice of Clinical Pharmacology and Therapeutics, 3rd ed. Williams and Wilkins, Baltimore (1987) 50-56.
Spilker, B., Guide to Clinical Studies and Developing Protocols, Raven Press Books, Ltd., New York (1984) 7-13, 54-60.
Spilker, B., Guide to Clinical Trials, Raven Press, Ltd., New York, (1991) 93-101.
Szekanecz, Z. et al., Chemokines and angiogenesis, Current Opinion in Rheumatology (2001) 13(3):202-208.
Tallarida, R. et al., Principles in General Pharmacology, Springer-Verlag, New York, (1988) 18-20.
Taylor, P.C., “Anti-tumor necrosis factor therapies,” Current Opinion in Rheumatology (2001) 13(3):164-169.
Tse, C.K. et al., “Preparation and characterisation of homogeneous neurotoxin type A fromClostridium botulinum,” Eur. J. Biochem. (1982) 122:493-500.
Wade, D. et al., “All-D amino acid-containing channel-forming antibiotic peptides,” Proc. Natl. Acad. Sci, USA (1990) 87:4761-4765.
Kundu et al., “Combinatorial Approach to Lead Optimization of a Novel Hexapeptide with Antifungal Activity,”Bioorganic&Medicinal Chemistry Letters, 10 (16): 1779-1781 (2000).
Supplementary Partial European Search Report issued in EP 03 76 3093 (2008).
Barnes & Thornburg LLP
Bio Science International, Inc.
Gross Christopher M.
Low Christopher
Martin Alice O.
LandOfFree
Peptides comprising aromatic D-amino acids and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptides comprising aromatic D-amino acids and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptides comprising aromatic D-amino acids and methods of use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4179802